AxoGen CEO Details Approach To Crisis Management During COVID-19
Source: Life Science Leader
During a virtual roundtable involving three CEOs of publicly traded biopharmaceutical companies (view full video here), Karen Zaderej, CEO, AxoGen, details the decision to move to a disaggregated decision-making model during the COVID-19 crisis.
This website uses cookies to ensure you get the best experience on our website. Learn more